Eyemax-plus Firm Not Eye-To-Eye With NAD, But Complies With Findings
This article was originally published in The Tan Sheet
Executive Summary
Cambridge Institute for Better Vision drops claims that its Eyemax-plus supplement helps prevent macular degeneration and cancer and complies with other National Advertising Division recommendations, but contends the industry self-regulation group’s findings exceed FDA limits on dietary supplement claims.
You may also be interested in...
FTC Testimonial Guide Moves Past "Results Not Typical," Enters Blog Era
The Federal Trade Commission raised the bar on substantiation and disclosure of "typical results" in testimonials and endorsements in advertising, in a revised guide released Oct. 5
Humic Acid Nasal Sprays Recalled During Potential For Sales Boost Due To Phenylephrine Doubts
Biomic Sciences recalls all lots of ION* Sinus Support and ION* Biome Sinus after FDE testing found microbial contamination causing reasonable probability of life-threatening adverse events for patients or people who recently underwent nasal or sinus surgery.
Message Clear For Xylitol Nasal Spray Firm Xlear: ‘Capitalize’ On FDA’s Oral Phenylephrine Doubts
“Pharmaceuticals have their place, and many do wonderful things for health, but the science of nasal hygiene is clear,” says marketing director Joel Melton.